Kalabic Jasmina - Dept Clin Pharmacol & Pharmacometr, AbbVie Inc

基本信息

浏览量：26

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 103 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Shorter Crohn’s Disease Duration is Associated with Better Clinical and Endoscopic Outcomes with Risankizumab in Phase 3 Studies

Laurent Peyrin-Biroulet,Jean-Frederic Colombel,Edouard Louis,Marc Ferrante,Satoshi Motoya,Remo Panaccione,Joana Torres,Ryan C. Ungaro,Kristina Kligys,Jasmina Kalabic,Javier Zambrano,Yafei Zhang,Geert D’Haens

Gastro Hep Advances (2024)

引用0浏览0WOS引用

Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONno. 11 (2024): 881-897

引用0浏览0WOS引用

Su1751 ACHIEVEMENT OF CORTICOSTEROID-FREE CLINICAL, ENDOSCOPIC, AND HISTOLOGIC OUTCOMES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH RISANKIZUMAB: RESULTS FROM THE COMMAND STUDY

Edward V. Loftus,Gareth C. Parkes,Marc Ferrante,Julian Panes,Marla C. Dubinsky,Satoshi Tanida,Jasmina Kalabic,Yafei Zhang,Ramona C. Vladea,Patrick Hecht,Stefan Schreiber

GASTROENTEROLOGYno. 5 (2024): S796-S797

引用0浏览0引用

Su1792 EFFICACY OUTCOMES OF PLACEBO MAINTENANCE TREATMENT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO RESPONDED TO PLACEBO INDUCTION THERAPY: RESULTS FROM THE PHASE 3 COMMAND STUDY

Raja Atreya,Marc Ferrante,Anita Afzali, Giorgos Bamias,Millie D. Long,Ezequiel Neimark,Phillip Levine,Ling Cheng,Jasmina Kalabic,Patrick Hecht,Ramona C. Vladea, Stefan Schreiber

Gastroenterologyno. 5 (2024): S-815-S-816

引用0浏览0引用

Efficacy and Safety of Risankizumab by Baseline Corticosteroid Use and Achievement of Corticosteroid-Free Clinical and Endoscopic Outcomes in Patients with Moderately to Severely Active Crohn's Disease

Stefan Schreiber,Raymond K. Cross,Remo Panaccione,Geert D'Haens,Peter Bossuyt,Iris Dotan,Jean-Frederic Colombel,Edouard Louis,Marla C. Dubinsky,Kristina Kligys,Ezequiel Neimark,Alexandra Song,Javier Zambrano,Jasmina Kalabic,Erica Cheng,Yafei Zhang,Marc Ferrante

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2024)

引用0浏览0WOS引用

RISANKIZUMAB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: EFFICACY AND SAFETY IN THE RANDOMIZED PHASE 3 COMMAND

Stefan Schreiber,Remo Panaccione,Gareth C. Parkes, Laurent Peyrin-Biroulet,Marc Ferrante, Tadakazu Hisamatsu,Britta Siegmund,Jasmina Kalabic,Phillip Levine,Ezequiel Neimark,Kori Wallace, Su Chen,Ling Cheng,W. Rachel Duan,Alessandro Armuzzi, Luc Biedermann,Edward V. Loftus,Gil Melmed,Edouard Louis

GASTROENTEROLOGYno. 5 (2024): S238-S238

引用0浏览0引用

Early Endoscopic Outcomes after Risankizumab Are Associated with Fewer Hospitalisations and Surgeries in Crohn’s Disease

Brian G. Feagan,Jean-Frederic Colombel,Remo Panaccione,Stefan Schreiber,Marc Ferrante,Koji Kamikozuru,Christopher Ma,Wan-Ju Lee,Jenny Griffith,Namita Joshi,Kristina Kligys,Jasmina Kalabic,Si Xuan,Marla Dubinsky

Gastro Hep Advances (2024)

引用0浏览0引用

S1472 Efficacy of Risankizumab Maintenance Therapy by Clinical Remission and Endoscopic Improvement Status in Patients with Moderately to Severely Active Ulcerative Colitis: Post Hoc Analysis of the COMMAND Phase 3 Study

Remo Panaccione,Peter Bossuyt,Irina Blumenstein,Luc Biedermann,Joana Torres, Ramona Vladea,Ling Cheng, Yafei Zhang,Jasmina Kalabic, Karen Chien, Pierre Morisset,Gareth Parkes

American Journal of Gastroenterologyno. 10S (2024)

引用0浏览0引用

P593 Efficacy of Risankizumab in Patients with Moderately to Severely Active Ulcerative Colitis by Prior Advanced Therapy Failure and Mechanism of Action: Post Hoc Analysis of the INSPIRE and COMMAND Phase 3 Studies

Remo Panaccione,Édouard Louis,Jean–Frédéric Colombel,Geert DʼHaens,Laurent Peyrin‐Biroulet,M Dubinsky,Ken Takeuchi,Jasmina Kalabic, Philip Levine,Ezequiel Neimark, S Chen,Ling Cheng,W. Rachel Duan,Ramona C. Vladea, P M Hecht,Yuri Sánchez González,Stefanie Schreiber,Marc Ferrante

Journal of Crohn's and colitisno. Supplement_1 (2024): i1153-i1155

引用0浏览0引用

Efficacy of Risankizumab in Patients With Moderately to Severely Active Ulcerative Colitis by Prior Advanced Therapy Failure and Mechanism of Action: Post Hoc Analysis of the INSPIRE and COMMAND Phase 3 Studies

R. Panaccione,E. Louis,J. F. Colombel,G. D'Haens,L. Peyrin-Biroulet,M. Dubinsky, K. Takeuchi,J. Kalabic, P. Levine,E. Neimark, S. Chen, L. Cheng, W. R. Duan,R. Vladea, P. M. Hecht,Y. Sanchez Gonzalez, S. Schreiber,M. Ferrante

JOURNAL OF CROHNS & COLITIS (2024): I1146-I1148

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn